News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Cadence Pharmaceuticals, Inc. May Buy Incline Therapeutics for up to $285 Million


6/22/2010 6:55:01 AM

Silicon Valley / San Jose Business Journal -- Cadence Pharmaceuticals Inc. on Monday said it has acquired an option to buy Incline Therapeutics Inc.for up to $285 million.


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES